On September 2, 2017, the annual meeting of the national pharmaceutical industry information center (34th), hosted by China medical industry information center, was opened in chengdu, and cypress blue was invited to attend.
Pharmaceutical industry top three: yangzijiang, guangyao, revision
Conference issued the ministry's list of top 2016 enterprise of China's pharmaceutical industry: Yangtze river pharmaceutical group co., LTD., guangzhou pharmaceutical group co., LTD., correction pharmaceutical group co., LTD. In the top three.
Yangzijiang, amendment and guangyao have been honored for two consecutive years. Given the combined influence of the three companies in the industry, the performance is not surprising.
According to the statistics and analysis of the China medical industry information center, the top 100 enterprises have accumulated a total revenue of 6809 billion yuan from the pharmaceutical industry, up 11.1% year on year. The minimum threshold for the top 100 list has also been further increased to 2.4 billion yuan, and the average size of the top 100 companies is expanding at a high speed.
Three medical device companies made the list
In the top of this year, a total of three in medical equipment for the main business of the company on the list, including the 11th weigao group co., LTD., 82, Baxter (China) investment co., LTD and Germany 97 (Beijing) medical equipment co., LTD.
Compared with last year, the group was down from 8th place to 11th, while Baxter China rose one.
Among them, lotte medical is making the list for the first time this year. In the same way, it also includes the products of Jilin Aodong Pharmaceutical Group Co., Ltd., anstam pharmaceuticals (China) Co., Ltd., Chengdu Kanghong Pharmaceutical Group Co., Ltd., and heilongjiang rare island Pharmaceutical Co., Ltd.
There are ups and downs.
There were four drug companies that fell out of the top 100. They are: China pharmaceutical technology co., LTD., echo group co., LTD., double pigeon group co., LTD., yichang dongguang pharmaceutical co., LTD.
At the same time, compared with the 2015 list, heze ruiying, dusha pharmaceutical, chengdu double, jiangsu yabang, huishi pharmaceutical and luye investment group, ranked in the decline of 10 places.
Attached: 2016 China medical industry top 100
|
